1. P702: FIRST INTERIM RESULTS OF THE PROSPECTIVE STUDY OF DOSE REDUCTION AND DISCONTINUATION OF TYROSINE KINASE INHIBITORS (READIT-2020) IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE. (23rd June 2022) Authors: Gurianova, M.; Shukhov, O.; Chelysheva, E.; Petrova, A.; Bykova, A.; Nemchenko, I.; Kuzmina, E.; Tsyba, N.; Gavrilova, L.; Stepanova, E.; Kohno, A.; Turkina, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P708: CANADIAN AND RUSSIAN EXPERIENCES OF ASCIMINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WHO FAILED MULTIPLE LINES OF TYROSINE KINASE INHIBITOR (TKI) THERAPY. (23rd June 2022) Authors: Khadadah, F.; Turkina, A. G.; Lomaia, E.; Morozova, E. V.; Shukhov, O. A.; Petrova, A.; Chitanava, T.; Vlasova, J. J.; Kuzmina, E.; Nemchenko, I.; Chelysheva, E. Y.; Bykova, A.; Gurianova, M.; Xenocostas, A.; Busque, L.; Jamani, K.; Cerquozzi, S.; Kuruvilla, P.; Kaedbey, R.; Leber, B. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P718: ASCIMINIB MANAGED-ACCESS PROGRAM (MAP) IN RUSSIA. (23rd June 2022) Authors: Shukhov, O.; Turkina, A.; Lomaia, E.; Morozova, E.; Petrova, A.; Chitanava, T.; Vlasova, Y.; Chelysheva, E.; Kuzmina, E.; Nemchenko, I.; Bykova, A.; Gurianova, M.; Kohno, A.; Parovichnikova, E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗